论文部分内容阅读
目的:观察白蛋白合并高通量透析在尿毒症心衰中的治疗效果。方法:搜集2013年3月-2014年5月我院接收的尿毒症合心衰59例患者,按照治疗方法不同分为对照组与研究组。给予对照组29例低通量透析治疗,给予研究组30例白蛋白并高通量透析治疗。观察对照组与研究组的治疗效果,并对比。结果:与对照组相比,研究组LVDd、EF、LVMI改善明显,有较大差异,有统计学意义(P<0.05)。结论:白蛋白并高通量透析在尿毒症心衰中的治疗效果较好,能有效改善患者LVDd、EF、LVMI,值得推广。
Objective: To observe the therapeutic effect of albumin combined with high-throughput dialysis in uremic heart failure. Methods: From March 2013 to May 2014, 59 patients with uremia and heart failure received in our hospital were divided into control group and study group according to different treatment methods. In the control group, 29 cases were treated with low-flux dialysis and 30 cases of study albumin were treated with high-throughput dialysis. The control group and study group were observed and compared. Results: Compared with the control group, the LVDd, EF and LVMI in the study group improved obviously, with significant difference (P <0.05). Conclusion: Albumin and high-throughput dialysis in the treatment of uremic heart failure is better, can effectively improve the LVDd, EF, LVMI, worthy of promotion.